Stroke Trial, Recruiting NCT06268041 Sponsor: University of Cincinnati Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06268041
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 30 to 85 years at the time of signing consent
  • People who have weakness on one side of the body caused by one or more strokes (either a blocked blood vessel or a bleed in the brain)
  • People whose most recent stroke (for which they received treatment) happened at least 6 months before joining the study
  • People whose walking speed is slower than 1.0 metre per second on a standard 10-metre walking test
  • People who can walk 10 metres on their own — with a walking aid if needed — without needing another person to physically support them the whole time (a helper standing nearby or giving occasional balance support is allowed)
  • People who can walk on a treadmill for at least 3 minutes at a very slow speed (0.13 metres per second or 0.3 miles per hour)
  • People who have a stable heart condition that falls within a specific medical category (known as AHA Class B — confirm with trial site for details)
  • People who are able to have a conversation with the research team, follow a two-step instruction, and correctly answer questions to show they understand what they are consenting to

Who may not be able to join:

  • People whose heart activity at rest makes it impossible to check for heart problems during exercise testing, unless recent heart test results from the past year are available to rule those problems out
  • People who show signs of a significant irregular heartbeat or reduced blood flow to the heart during a treadmill exercise test, unless more detailed heart testing from the past year showed a clear result
  • People who were admitted to hospital for a heart or lung condition within the past 3 months
  • People with an implanted pacemaker or defibrillator that has an upper heart rate limit that would interfere with exercise testing or exercise prescription, or where the limit is unknown
  • People with significant problems with balance/coordination or with ignoring one side of their body, based on a standard stroke assessment score (confirm with trial site)
  • People with severe muscle stiffness in the lower limbs, based on a standard stiffness scale (confirm with trial site)
  • People with a known recent history (within the past 3 months) of substance misuse or mental illness that is not stable
  • People with significant depression after their stroke (based on a standard questionnaire score) who are not currently receiving depression treatment from a healthcare provider
  • People who are currently taking part in physiotherapy or another study aimed at improving walking
  • People who have recently changed (within 2 weeks) or are planning to change their leg brace or muscle stiffness treatments
  • People who have foot drop or unstable leg joints without an appropriate supportive device, as assessed by a physiotherapist
  • People with a significant neurological condition other than stroke
  • People who were unable to walk outside the home before their stroke
  • People with another significant medical condition that a physiotherapist determines is likely to limit improvement or affect safety (for example, joint stiffness or pain that limits walking)
  • People who are pregnant
  • People who have had more than 3 hours total of fast treadmill walking in the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pierce Boyne, PT, DPT, PhD, University of Cincinnati

Phone: 513-558-7487

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Cincinnati
Registry
ClinicalTrials.gov
Start date
9 February 2024
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

6-Minute Walk Test Distance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov